Did you miss Thermo Fisher Scientific at CPHI Barcelona? You can still connect with our team post-show.
There are many considerations when establishing your plasmid DNA manufacturing strategy from a technical, quality, and regulatory perspective, many of which can be addressed by leveraging a knowledgeable CDMO partner. Watch this on-demand webinar for an in-depth overview of common challenges facing advanced therapy developers using pDNA, as well as strategies to mitigate risk and achieve both cost and quality goals in plasmid manufacturing.
Key takeaways include: